Genetic Variation Of Enzyme Linked With Outcomes For Women Receiving Tamoxifen, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Study  
10/7/2009 7:24:12 AM

Bookmark and Share

EurekAlert! -- Among women with early stage breast cancer, genetic variation of a certain enzyme appears to be associated with clinical outcomes for women treated with tamoxifen, according to a study in the October 7 issue of JAMA.